George Kemble's most recent trade in Sagimet Biosciences Inc - Ordinary Shares - Class A was a trade of 32,250 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sagimet Biosciences Inc - ... | George Kemble | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2025 | 32,250 | 32,250 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 3.17 per share. | 23 Jul 2024 | 23,625 | 118,693 | - | 3.2 | 74,830 | Series A Common Stock |
| Sagimet Biosciences Inc - ... | George Kemble | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 3.10 per share. | 19 Jul 2024 | 14,062 | 142,318 | - | 3.1 | 43,605 | Series A Common Stock |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2023 | 526,332 | 0 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 526,332 | 526,332 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2023 | 367,824 | 0 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 367,824 | 367,824 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2023 | 46,432 | 0 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 46,432 | 46,432 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2023 | 26,352 | 0 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 26,352 | 26,352 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 21,173 | 21,173 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2023 | 21,173 | 0 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2023 | 7,147 | 0 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 7,147 | 7,147 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2023 | 5,630 | 0 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 5,630 | 5,630 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 18 Jul 2023 | 3,179 | 0 | - | - | Stock Option (Right to Buy) | |
| Sagimet Biosciences Inc - ... | George Kemble | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 3,179 | 3,179 | - | - | Stock Option (Right to Buy) |